tiprankstipranks
Trending News
More News >
Jade Biosciences (JBIO)
NASDAQ:JBIO
US Market

Jade Biosciences (JBIO) Stock Investors

Compare
145 Followers
Based on 803,257 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold JBIO
On average, investors allocate 0.00% of their portfolios to JBIO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 803,257 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding JBIO

1.6%
Last 7
Days
5.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding JBIO, out of 803,257 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

JBIO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$9.95
Based on the activity of investors who made their portfolios public
The table shows changes in JBIO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

JBIO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
4.29%
+1.40%
+4.80%
33.40B
Consumer Cyclical
Lucid Group
5.18%
-0.60%
+0.16%
6.68B
Consumer Cyclical
Recursion Pharmaceuticals
3.18%
+0.65%
-0.74%
2.22B
Healthcare
CVS Health
3.97%
-1.12%
-2.81%
81.29B
Healthcare
NextEra Energy
3.42%
+0.31%
+2.71%
149.89B
Utilities
Delta Air Lines
4.60%
-1.30%
-2.97%
33.74B
Industrials
BigBearai Holdings
4.02%
+1.85%
+4.58%
1.10B
Technology
Viking Therapeutics
3.70%
-1.04%
-4.22%
3.27B
Healthcare
Zscaler
3.69%
+1.43%
+3.93%
46.39B
Technology
Abbott Laboratories
3.31%
-0.76%
-2.33%
233.36B
Healthcare
Based on the activity of 803,257 active portfolios
Open your Smart Portfolio

JBIO Investor Analysis

JBIO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.2%
of JBIO holders
are under 35
Average Segment Performance
Average P/E Ratio20.53
Beta4.60
Dividend Yield4.09%
JBIO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
63.6%
of JBIO holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.79
Beta11.42
Dividend Yield3.52%
JBIO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
18.2%
of JBIO holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta3.72
Dividend Yield3.81%
Overview of age group and performance of JBIO stock investors
See who invests in JBIO according to age group and performance.

FAQ

How many retail Investors hold JBIO?
<0.1% of TipRanks' retail investors hold JBIO in their portfolios.
    What is JBIO Investor Sentiment?
    JBIO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of JBIO in the last 7 days?
      ▼ 1.6% of TipRanks' retail investors changed their holding of JBIO in the last 7 days.
        What percentage of retail investors changed their holding of JBIO in the last 30 days?
        ▼ 5.8% of TipRanks' retail investors changed their holding of JBIO in the last 30 days.
          What is the average age of retail investors who hold JBIO?
          The average age of JBIO Holders is between 35–55.
            What other stocks have JBIO investors also bought?
            JBIO Investors also bought DKNG, LCID, RXRX, CVS, NEE, DAL, BBAI, VKTX, ZS, ABT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis